Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma, Invest Ophthalmol Vis Sci, vol.42, pp.313-317, 2001. ,
Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background, Cancer Res, vol.65, pp.4005-4011, 2005. ,
Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin, Cell, vol.139, pp.366-379, 2009. ,
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies, Cancer, vol.122, pp.3344-3353, 2016. ,
A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib, J Invest Dermatol, vol.134, pp.1473-1476, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02530592
Cancerassociated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage, Nature communications, vol.7, p.10615, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01272099
Mimulone-induced autophagy through p53-mediated AMPK/mTOR pathway increases caspase-mediated apoptotic cell death in A549 human lung cancer cells, PloS one, vol.9, p.114607, 2014. ,
Two distinct types of mouse melanocyte: differential signaling requirement for the maintenance of noncutaneous and dermal versus epidermal melanocytes, Development, vol.136, pp.2511-2521, 2009. ,
Genetics of familial melanoma: 20 years after CDKN2A, Pigment Cell Melanoma Res, vol.28, pp.148-160, 2015. ,
Recurrent inactivating RASA2 mutations in melanoma, Nat Genet, vol.47, pp.1408-1410, 2015. ,
Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma, The American journal of surgical pathology, vol.1, pp.131-143, 1977. ,
Molecular pathways mediating liver metastasis in patients with uveal melanoma, Clin Cancer Res, vol.14, pp.951-956, 2008. ,
, New TNM melanoma staging system: linking biology and natural history to clinical outcomes, vol.21, pp.43-52, 2003.
The influence of inner ear melanin on susceptibility to TTS in humans, Scandinavian audiology, vol.19, pp.97-102, 1990. ,
The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia, Annual review of pathology, vol.9, pp.239-271, 2014. ,
Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization, Cancer Res, vol.58, pp.2170-2175, 1998. ,
Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations, J Invest Dermatol, vol.127, pp.179-182, 2007. ,
KIT gene mutations and copy number in melanoma subtypes, Clin Cancer Res, vol.14, pp.6821-6828, 2008. ,
Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice, J Biol Chem, vol.279, pp.46129-46134, 2004. ,
How to make a melanoma: what do we know of the primary clonal events?, Pigment Cell Melanoma Res, vol.21, pp.27-38, 2008. ,
Melanoma genome sequencing reveals frequent PREX2 mutations, Nature, vol.485, pp.502-506, 2012. ,
Melanoma: from melanocyte to genetic alterations and clinical options, p.635203, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02530599
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes, J Cell Biol, vol.142, pp.827-835, 1998. ,
URL : https://hal.archives-ouvertes.fr/inserm-02532974
Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia, Mol Cell Biol, vol.18, pp.694-702, 1998. ,
URL : https://hal.archives-ouvertes.fr/inserm-02533084
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma, Nature, vol.480, pp.94-98, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00719536
Sunlight ultraviolet irradiation and BRAF V600 mutagenesis in human melanoma, Hum Mutat, vol.29, pp.983-991, 2008. ,
G-to-T transversions and small tandem base deletions are the hallmark of mutations induced by ultraviolet a radiation in mammalian cells, Biochemistry, vol.43, pp.8169-8177, 2004. ,
Targeting the translation machinery in cancer, Nature reviews Drug discovery, vol.14, pp.261-278, 2015. ,
Identification of TRIO-GEFD1 chemical inhibitors using the yeast exchange assay, Biology of the cell, vol.98, pp.511-522, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-02267406
Deciphering the role of oncogenic MITFE318K in senescence delay and melanoma progression J Natl Cancer, 2017. ,
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies, Nature, vol.513, pp.105-109, 2014. ,
Deregulation of the Rb and p53 pathways in uveal melanoma, Am J Pathol, vol.157, pp.1795-1801, 2000. ,
, Inactivation of retinoblastoma protein in uveal melanoma by phosphorylation of sites in the COOH-terminal region, Cancer Res, vol.60, pp.4320-4323, 2000.
The protective role of melanin against UV damage in human skin, Photochemistry and photobiology, vol.84, pp.539-549, 2008. ,
Genetic and environmental factors in cutaneous malignant melanoma, Biochimie, vol.84, pp.67-74, 2002. ,
Neural crest cell formation and migration in the developing embryo, FASEB J, vol.8, pp.699-706, 1994. ,
, Genomic Classification of Cutaneous Melanoma, Cancer Genome Atlas N, vol.161, pp.1681-1696, 2015.
MC1R is a potent regulator of PTEN after UV exposure in melanocytes, Mol Cell, vol.51, pp.409-422, 2013. ,
Ipilimumab Combined with Nivolumab: A Standard of Care for the Treatment of Advanced Melanoma?, Clin Cancer Res, vol.22, pp.3992-3998, 2016. ,
Relationships between melanocytes, mechanical properties and extracellular matrix composition in mouse heart valves, Journal of long-term effects of medical implants, vol.25, pp.17-26, 2015. ,
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness, Genes Dev, vol.20, pp.3426-3439, 2006. ,
KIT as a therapeutic target in metastatic melanoma, JAMA, vol.305, pp.2327-2334, 2011. ,
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial, Jama, vol.311, pp.2397-2405, 2014. ,
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer discovery, vol.2, pp.401-404, 2012. ,
Uveal melanoma: From diagnosis to treatment and the science in between, Cancer, vol.122, pp.2299-2312, 2016. ,
Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny, Oncogene, vol.30, pp.2307-2318, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-02530763
Fifteen-year quest for microphthalmia-associated transcription factor target genes, Pigment Cell Melanoma Res, vol.23, pp.27-40, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-02530740
8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G----T and A----C substitutions, J Biol Chem, vol.267, pp.166-172, 1992. ,
The biologic forms of malignant melanoma, Hum Pathol, vol.17, pp.443-450, 1986. ,
A caveolin-dependent and PI3K/AKTindependent role of PTEN in beta-catenin transcriptional activity, Nature communications, vol.6, p.8093, 2015. ,
Somatic activation of KIT in distinct subtypes of melanoma, J Clin Oncol, vol.24, pp.4340-4346, 2006. ,
Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification, Clin Cancer Res, vol.16, pp.6083-6092, 2010. ,
beta-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas, Cancer Cell, vol.20, pp.741-754, 2011. ,
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy, Cancer immunology, immunotherapy : CII, vol.61, pp.41-48, 2012. ,
Braf(V600E) cooperates with Pten loss to induce metastatic melanoma, Nat Genet, vol.41, pp.544-552, 2009. ,
Mutations of the BRAF gene in human cancer, Nature, vol.417, pp.949-954, 2002. ,
A novel AKT3 mutation in melanoma tumours and cell lines, Br J Cancer, vol.99, pp.1265-1268, 2008. ,
Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism, PloS one, vol.10, p.138002, 2015. ,
Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes, JAMA ophthalmology, vol.134, pp.728-733, 2016. ,
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development, Genes Dev, vol.21, pp.2923-2935, 2007. ,
Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway, Nat Cell Biol, vol.8, pp.1053-1063, 2006. ,
MAP kinase signalling pathways in cancer, Oncogene, vol.26, pp.3279-3290, 2007. ,
Oncogenic Braf induces melanocyte senescence and melanoma in mice, Cancer Cell, vol.15, pp.294-303, 2009. ,
Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma, Archives of ophthalmology, vol.123, pp.1639-1643, 2005. ,
Intraocular melanoma spread to regional lymph nodes: report of two cases, Retina, vol.20, pp.76-79, 2000. ,
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer, Cell metabolism, vol.22, pp.577-589, 2015. ,
Integrative genomic analysis of aneuploidy in uveal melanoma, Clin Cancer Res, vol.14, pp.115-122, 2008. ,
MEK1 mutations confer resistance to MEK and B-RAF inhibition, Proc Natl Acad Sci U S A, vol.106, pp.20411-20416, 2009. ,
Single-cell gene expression signatures reveal melanoma cell heterogeneity, Oncogene, vol.34, pp.3251-3263, 2015. ,
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma, Genes Dev, 2017. ,
Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trioregulated rho GTPase signaling circuitry, Cancer Cell, vol.25, pp.831-845, 2014. ,
Genetic markers of pigmentation are novel risk loci for uveal melanoma, Scientific reports, vol.6, p.31191, 2016. ,
PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma, Clin Cancer Res, vol.22, pp.1234-1242, 2016. ,
Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas, Oncotarget, 2016. ,
Recent developments in prognostic and predictive testing in uveal melanoma, Current opinion in ophthalmology, vol.25, pp.234-239, 2014. ,
Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a, Science, vol.325, pp.1261-1265, 2009. ,
Lifetime risks of common cancers among retinoblastoma survivors, J Natl Cancer Inst, vol.96, pp.357-363, 2004. ,
Investigation of Somatic GNAQ, GNA11, BAP1 and SF3B1 Mutations in Ophthalmic Melanocytomas, Ocular oncology and pathology, vol.2, pp.171-177, 2016. ,
DEF-1/ASAP1 is a GTPase-activating protein (GAP) for ARF1 that enhances cell motility through a GAP-dependent mechanism, J Biol Chem, vol.277, pp.7962-7969, 2002. ,
SF3B1 mutations are associated with alternative splicing in uveal melanoma, Cancer discovery, vol.3, pp.1122-1129, 2013. ,
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Science signaling, vol.6, p.1, 2013. ,
Guilty as charged: B-RAF is a human oncogene, Cancer Cell, vol.6, pp.313-319, 2004. ,
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma, Nature, vol.436, pp.117-122, 2005. ,
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history, Pigment Cell Melanoma Res, vol.26, pp.259-262, 2013. ,
Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas, Cancer Res, vol.70, pp.3813-3822, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-02530789
Pathology and genetics of uveal melanoma, Pathology, vol.45, pp.18-27, 2013. ,
Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas, Clin Cancer Res, vol.19, pp.3143-3152, 2013. ,
Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations, JAMA ophthalmology, vol.133, pp.881-887, 2015. ,
Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study, p.68, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01406639
Frequent mutation of BAP1 in metastasizing uveal melanomas, Science, vol.330, pp.1410-1413, 2010. ,
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma, Nat Genet, vol.45, pp.133-135, 2013. ,
Cancer mutation signatures, DNA damage mechanisms, and potential clinical implications, Genome medicine, vol.5, p.87, 2013. ,
Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma, Invest Ophthalmol Vis Sci, vol.44, pp.458-462, 2003. ,
Role of MC1R variants in uveal melanoma, Br J Cancer, vol.89, pp.1961-1965, 2003. ,
MC1R signaling. Intracellular partners and pathophysiological implications, Biochim Biophys Acta, 2017. ,
Improved survival with ipilimumab in patients with metastatic melanoma, N Engl J Med, vol.363, pp.711-723, 2010. ,
A landscape of driver mutations in melanoma, Cell, vol.150, pp.251-263, 2012. ,
In vivo switching of human melanoma cells between proliferative and invasive states, Cancer Res, vol.68, pp.650-656, 2008. ,
Cancer stem cells versus phenotype-switching in melanoma, Pigment Cell Melanoma Res, vol.23, pp.746-759, 2010. ,
TERT promoter mutations in familial and sporadic melanoma, Science, vol.339, pp.959-961, 2013. ,
Replication Study: Melanoma genome sequencing reveals frequent PREX2 mutations, vol.6, 2017. ,
Tumour exosome integrins determine organotropic metastasis, Nature, vol.527, pp.329-335, 2015. ,
Germline p16 mutations in familial melanoma, Nat Genet, vol.8, pp.15-21, 1994. ,
Germline mutations in BAP1 impair its function in DNA double-strand break repair, Cancer Res, vol.74, pp.4282-4294, 2014. ,
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers, PloS one, vol.6, p.22769, 2011. ,
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition, Nature, vol.504, pp.138-142, 2013. ,
Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4, Oncotarget, vol.7, pp.4624-4631, 2016. ,
Ocular melanoma: an overview of the current status, International journal of clinical and experimental pathology, vol.6, pp.1230-1244, 2013. ,
The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma, Nature reviews Clinical oncology, vol.10, pp.588-598, 2013. ,
Intra-and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts, EMBO molecular medicine, vol.7, pp.1104-1118, 2015. ,
Conjunctival melanoma and melanocytic intra-epithelial neoplasia, Eye (Lond), vol.27, pp.142-152, 2013. ,
A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors, Cancer discovery, 2014. ,
The use of pembrolizumab for the treatment of metastatic uveal melanoma, Melanoma Res, vol.26, pp.300-303, 2016. ,
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas, Nat Genet, vol.47, pp.996-1002, 2015. ,
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma, Nat Genet, vol.44, pp.1006-1014, 2012. ,
Familial uveal melanoma: report on three sibling cases, The British journal of ophthalmology, vol.85, pp.1007-1008, 2001. ,
Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions, Ophthalmology, vol.112, pp.1135-1144, 2005. ,
Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma, Clin Cancer Res, vol.18, pp.408-416, 2012. ,
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation, Nature, vol.490, pp.412-416, 2012. ,
The WNT/Beta-catenin pathway in melanoma, Frontiers in bioscience : a journal and virtual library, vol.11, pp.733-742, 2006. ,
Mutational heterogeneity in cancer and the search for new cancer-associated genes, Nature, vol.499, pp.214-218, 2013. ,
Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers, J Clin Invest, vol.119, pp.3420-3436, 2009. ,
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma, N Engl J Med, vol.371, pp.1877-1888, 2014. ,
Structural insights into phospholipase C-beta function, Molecular pharmacology, vol.84, pp.488-500, 2013. ,
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma, Clinical therapeutics, vol.37, pp.764-782, 2015. ,
Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3, Nat Genet, vol.45, pp.933-936, 2013. ,
Leukotriene D4-induced adhesion of Caco-2 cells is mediated by prostaglandin E2 and upregulation of alpha2beta1-integrin, Exp Cell Res, vol.289, pp.342-351, 2003. ,
BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma, BMC cancer, vol.13, p.371, 2013. ,
The neural crest, Development, vol.140, pp.2247-2251, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01712198
Influence of immune privilege on ocular tumor development, Ocular immunology and inflammation, vol.18, pp.80-90, 2010. ,
Incidence of noncutaneous melanomas in the U, S. Cancer, vol.103, pp.1000-1007, 2005. ,
Characterization of melanocortin-1 receptor gene variants in uveal melanoma patients, Invest Ophthalmol Vis Sci, vol.42, pp.1951-1954, 2001. ,
Reflecting on 25 years with MYC, Nat Rev Cancer, vol.8, pp.976-990, 2008. ,
Pro-inflammatory mediator leukotriene D4 induces transcriptional activity of potentially oncogenic genes, Biochemical Society transactions, vol.33, pp.698-700, 2005. ,
BRAFE600-associated senescence-like cell cycle arrest of human naevi, Nature, vol.436, pp.720-724, 2005. ,
Epigenetic silencing of the PTEN gene in melanoma, Cancer Res, vol.66, pp.6546-6552, 2006. ,
Conjunctival melanoma in the Netherlands: a nationwide study, Invest Ophthalmol Vis Sci, vol.46, pp.75-82, 2005. ,
An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background, Nature, vol.491, pp.449-453, 2012. ,
Leukotriene D4 receptor-mediated hydrolysis of phosphoinositide and mobilization of calcium in sheep tracheal smooth muscle cells, The Journal of pharmacology and experimental therapeutics, vol.244, pp.508-515, 1988. ,
Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma, Nat Genet, vol.48, pp.675-680, 2016. ,
Leukotrienes C4 and D4 as potent mitogens for cultured human neonatal melanocytes, J Invest Dermatol, vol.93, pp.719-722, 1989. ,
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma, Nature communications, vol.5, p.5712, 2014. ,
ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients, Oncogene, vol.29, pp.2393-2403, 2010. ,
GNAQ and GNA11 mutations in melanocytomas of the central nervous system, Acta neuropathologica, vol.123, pp.457-459, 2012. ,
Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma, J Invest Dermatol, vol.134, pp.123-132, 2014. ,
Genomic Classification of Cutaneous Melanoma, Cell, vol.161, pp.1681-1696, 2015. ,
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma, Nat Genet, vol.44, pp.133-139, 2011. ,
Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS), Genes Dev, vol.25, pp.1245-1261, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-02530715
Uveal melanoma as a target for immunetherapy, Annals of translational medicine, vol.4, p.172, 2016. ,
Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas, Cancer Res, vol.66, pp.4602-4609, 2006. ,
Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death, Cancer Res, vol.64, pp.7205-7209, 2004. ,
Association between gene expression profile, proliferation and metastasis in uveal melanoma, Current eye research, vol.35, pp.857-863, 2010. ,
Oncogenic mutations in GNAQ occur early in uveal melanoma, Invest Ophthalmol Vis Sci, vol.49, pp.5230-5234, 2008. ,
An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma, The Journal of molecular diagnostics : JMD, vol.12, pp.461-468, 2010. ,
Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence, Proc Natl Acad Sci U S A, vol.113, pp.5024-5033, 2016. ,
Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes, Melanoma Res, vol.13, pp.483-492, 2003. ,
Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site, Molecular oncology, vol.1, pp.395-405, 2008. ,
High frequency of BRAF mutations in nevi, Nat Genet, vol.33, pp.19-20, 2003. ,
The genetics of sun sensitivity in humans, Am J Hum Genet, vol.75, pp.739-751, 2004. ,
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment, Nature communications, vol.6, p.8755, 2015. ,
Variates of survival in metastatic uveal melanoma, J Clin Oncol, vol.23, pp.8076-8080, 2005. ,
Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing, Am J Hum Genet, 2016. ,
Properties and function of the ocular melanin--a photobiophysical view, Journal of photochemistry and photobiology B, Biology, vol.12, pp.215-258, 1992. ,
Occupational exposure to vinyl chloride, acrylonitrile and styrene and lung cancer risk (europe), Cancer Causes Control, vol.15, pp.445-452, 2004. ,
Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair, Biochem Biophys Res Commun, vol.260, pp.488-491, 1999. ,
Aptamer-derived peptide inhibitors of Rho guanine nucleotide exchange factors. The Enzymes 33 Pt A, pp.147-168, 2013. ,
The experimental power of FR900359 to study Gq-regulated biological processes, Nature communications, vol.6, p.10156, 2015. ,
Host factors, UV radiation, and risk of uveal melanoma. A case-control study, Archives of ophthalmology, vol.108, pp.1274-1280, 1990. ,
Genetically modified T cells in cancer therapy: opportunities and challenges, Disease models & mechanisms, vol.8, pp.337-350, 2015. ,
The RB and p53 pathways in cancer, Cancer Cell, vol.2, pp.103-112, 2002. ,
Prognosis of uveal melanoma in 500 cases using genetic testing of fineneedle aspiration biopsy specimens, Ophthalmology, vol.118, pp.396-401, 2011. ,
Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases, Ophthalmology, vol.118, pp.389-395, 2011. ,
Pathways and therapeutic targets in melanoma, Oncotarget, vol.5, pp.1701-1752, 2014. ,
Novel somatic mutations to PI3K pathway genes in metastatic melanoma, PloS one, vol.7, p.43369, 2012. ,
Uveal melanoma: epidemiologic aspects, Ophthalmology clinics of North America, vol.18, pp.75-84, 2005. ,
Incidence of uveal melanoma in the United States: 1973-1997, Ophthalmology, vol.110, pp.956-961, 2003. ,
Melanocytes and the microphthalmia transcription factor network, Annu Rev Genet, vol.38, pp.365-411, 2004. ,
Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma, Oncogene, vol.30, pp.2319-2332, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-02530755
Genetics of human iris colour and patterns, Pigment Cell Melanoma Res, vol.22, pp.544-562, 2009. ,
Immunotherapy: Anti-PD-1 therapies-a new first-line option in advanced melanoma, Nature reviews Clinical oncology, vol.12, pp.2424-2435, 2015. ,
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes, Oncogene, vol.35, pp.2413-2427, 2016. ,
Sound needs sound melanocytes to be heard, Pigment Cell Res, vol.12, pp.344-354, 1999. ,
Neuroendocrine functions of melanocytes: beyond the skin-deep melanin maker, The Tohoku journal of experimental medicine, vol.211, pp.201-221, 2007. ,
Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors, Journal of oncology, p.647684, 2012. ,
Sporadic melanotic schwannoma with overlapping features of melanocytoma bearing a GNA11 mutation in an adolescent girl, Pediatric blood & cancer, 2016. ,
BRAF somatic mutations in malignant melanoma and melanocytic naevi, Melanoma Res, vol.16, pp.97-103, 2006. ,
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq, Science, vol.352, pp.189-196, 2016. ,
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab, J Clin Oncol, vol.32, pp.1020-1030, 2014. ,
Time trends in the incidence of conjunctival melanoma in Sweden, The British journal of ophthalmology, vol.93, pp.1524-1528, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00477850
Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases, Invest Ophthalmol Vis Sci, vol.50, pp.2572-2580, 2009. ,
PD-1 and PD-L1 antibodies for melanoma, Human vaccines & immunotherapeutics, vol.10, pp.3111-3116, 2014. ,
Cutaneous, ocular and visceral melanoma in African Americans and Caucasians, Melanoma Res, vol.15, pp.213-217, 2005. ,
The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate, Arch Dermatol, vol.139, pp.282-288, 2003. ,
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma, J Invest Dermatol, vol.122, pp.337-341, 2004. ,
Survival of patients with advanced metastatic melanoma: The impact of novel therapies, Eur J Cancer, vol.53, pp.125-134, 2016. ,
Ocular melanoma is not associated with CDKN2A or MC1R variants--a population-based study, Melanoma Res, vol.13, pp.409-413, 2003. ,
Sun exposure predicts risk of ocular melanoma in Australia, Int J Cancer, vol.101, pp.175-182, 2002. ,
Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis, Invest Ophthalmol Vis Sci, vol.53, pp.2668-2674, 2010. ,
Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma, Acta oncologica, vol.56, pp.5303-5306, 2001. ,
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi, Nature, vol.457, pp.599-602, 2009. ,
Mutations in GNA11 in uveal melanoma, N Engl J Med, vol.363, pp.2191-2199, 2010. ,
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state, Nature communications, vol.6, p.6683, 2015. ,
Digital PCR validates 8q dosage as prognostic tool in uveal melanoma, PloS one, vol.10, p.116371, 2015. ,
Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma, Cell reports, vol.4, pp.1090-1099, 2013. ,
Cancer genome landscapes, Science, vol.339, pp.1546-1558, 2013. ,
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis, Genes Dev, vol.26, pp.1055-1069, 2012. ,
Characterization of melanin in human iridal and choroidal melanocytes from eyes with various colored irides, Pigment Cell Melanoma Res, vol.21, pp.97-105, 2008. ,
Exome sequencing identifies GRIN2A as frequently mutated in melanoma, Nat Genet, vol.43, pp.442-446, 2011. ,
Genome-wide in vivo screen identifies novel host regulators of metastatic colonization, Nature, vol.541, pp.233-236, 2017. ,
Germline mutations in BAP1 predispose to melanocytic tumors, Nat Genet, vol.43, pp.1018-1021, 2011. ,
The anti-apoptotic effect of leukotriene D4 involves the prevention of caspase 8 activation and Bid cleavage, Biochem J, vol.371, pp.115-124, 2003. ,
Regulation of leukotriene-dependent induction of cyclooxygenase-2 and Bcl-2, Biochem Biophys Res Commun, vol.302, pp.330-335, 2003. ,
Neural crest cell lineage segregation in the mouse neural tube, Development, vol.131, pp.6153-6162, 2004. ,
The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer, Gene therapy, vol.15, pp.1193-1199, 2008. ,
Management of conjunctival malignant melanoma: a review and update, Expert review of ophthalmology, vol.9, pp.185-204, 2014. ,
PTEN signaling pathways in melanoma, Oncogene, vol.22, pp.3113-3122, 2003. ,
Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor, British journal of pharmacology, vol.160, pp.399-409, 2010. ,
Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases, Ophthalmology, vol.123, pp.1118-1128, 2016. ,
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma, Nature, vol.480, pp.99-103, 2011. ,
ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma, Cancer Cell, vol.29, pp.889-904, 2016. ,
Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP, Cancer Cell, vol.25, pp.822-830, 2014. ,
Current concepts of metastasis in melanoma, Expert review of dermatology, vol.3, pp.569-585, 2008. ,
Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease, J Neurochem, vol.106, pp.1866-1875, 2008. ,
Misregulation of pre-mRNA alternative splicing in cancer, Cancer discovery, vol.3, pp.1228-1237, 2013. ,
The genomic landscape of cutaneous melanoma, Pigment Cell Melanoma Res, vol.29, pp.266-283, 2016. ,
C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells, Oncogene, vol.27, pp.6623-6634, 2008. ,
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma, Nat Genet, vol.12, pp.97-99, 1996. ,